Microsporidiosis natural history, complications and prognosis
Microsporidiosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Microsporidiosis natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Microsporidiosis natural history, complications and prognosis |
FDA on Microsporidiosis natural history, complications and prognosis |
CDC on Microsporidiosis natural history, complications and prognosis |
Microsporidiosis natural history, complications and prognosis in the news |
Blogs on Microsporidiosis natural history, complications and prognosis |
Risk calculators and risk factors for Microsporidiosis natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Ahmed Younes M.B.B.CH [2]
Overview
If left untreated, immunocompetent patients resolve completely within 2 weeks while immunocompromised patients might develop chronic diarrhea. Common complications of microsporidiosis include weight loss, dehydration, and acalculous cholecystitis. Prognosis is generally excellent in immunocompetent patients while immunocompromised patients are more vulnerable to developing chronic disease and complications.
Natural History
If left untreated, microsporidiosis is self-resolving with complete recovery within 14 days in immunocompetent patients While in immunocompromised patients, the disease is more prolonged and patients are more vulnerable to complications as malnutrition and vitamin deficiencies.
Complications
Complication might arise in immunocompromised patients due to chronic diarrhea:
- Dehydration
- Weight loss
- Nutritional deficiencies
- Acalculous cholecystitis
- Systemic spread to the brain, respiratory tract, urinary tract, etc.
Prognosis
- The prognosis is excellent among immunocompetent patients with self-resolving of the disease within 2 weeks.
- In immunocompromised patients, the prognosis is less favorable with more vulnerability to develop systemic spread of the disease and complications.
- Mortality due to microsporidiosis is mostly associated with systemic disease and in patients not receiving HAART.